Q1 2022 Aurobindo Pharma Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to the Aurobindo's Pharma Q1 FY '22 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Arvind Bothra, Investor Relations. Thanks, and over to you, sir.
Thank you. Good morning, and a warm welcome to our first quarter FY '22 earnings call. I am Arvind Bothra from the Investor Relations team, Aurobindo Pharma Limited. We hope you have received the Q1 FY '22 financials and the press release that we sent out yesterday. The same is also available on our website.
With me, we have our senior management team represented by Mr. P.V. Ramprasad Reddy, Chairman, Aurobindo Pharma USA; Mr. N. Govindarajan, Managing Director, Aurobindo Pharma Limited; Mr. Sanjeev Dani, COO and Head, Formulations; Mr. Santhanam Subramanian, CFO; and Mr. Swami Iyer, CFO, Aurobindo Pharma USA. We will begin the call with summary highlights from the management followed by an
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
